No, why would you claim that?
There is a concept of subgroup analysis in studies like these, but you have to be careful about how it’s done and what conclusions are drawn. If you simply select positive results and exclude negative results then even the placebo group would show great success.
This study showed that telling people that they were microdosing was more important for the perceived outcome than the micro dosing itself. In other words, placebo is key to making it work.
Where did zosima ask to do that? They mentioned that the variable of comparison should be changes from baseline metrics in treatment group vs changes from baseline metrics in control group. That would be a fair study, and isn't cherry picking.